![](https://img.einnews.com/small/703243/opioid-withdrawal-syndrome-mark.jpeg)
Opioid Withdrawal Syndrome Market Report 2034: Epidemiology, Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight
Opioid Withdrawal Syndrome companies are atai Life Sciences, Medicinova, BioXcel Therapeutics Inc., and others. LAS VEGAS, NEVADA, UNITED STATES, July 10, 2024 /EINPresswire.com/ -- DelveInsight’s “Opioid Withdrawal Syndrome Market Insights, …